The global market for cytotoxicity assays is projected to register a Y-o-Y increase of 8.4% in 2022 to be valued at US$ 13,803.92 Million. As of 2021, cytotoxicity assays demand was valued at US$ 12,732.37 Million. During the 2022 to 2032 assessment period, the industry is likely to expand at a CAGR of 9.1%.
| Report Attribute | Details |
|---|---|
| Estimated Base Year Value (2021) | US$ 12,732.37 Million |
| Expected Market Value (2022) | US$ 13,803.92 Million |
| Anticipated Forecast Value (2032) | US$ 32,978.94 Million |
| Projected Growth Rate (2022 to 2032) | 9.1% CAGR |
Cytotoxicity assays are primarily used to determine the effects of hazardous substances or physiological changes in cell type health. Cytotoxicity assays are the most commonly used tool for quantifying cell exposure to a cytotoxic stimulus.
Furthermore, cytotoxicity assays can be used to determine metabolic activity, cell growth inhibition, or cell division. The Cytotoxicity Assay also assists analysts and clinicians in determining the toxicity level of a specific medication or drugs to be used in the market.
One of the most important indicators used in the biological evaluation system is the cytotoxicity assay. Many experimental methods for evaluating cell cytotoxicity are constantly being developed and modernized as modern cell biology advances. Furthermore, some manufacturers have developed real-time and dynamic methods for quantifying cell morphology, proliferation, and differentiation in cytotoxicity assays.
Following this, other players are attempting to incorporate new real-time cell analysis system technologies into in vitro cytotoxicity tests of medical devices in order to meet the objectives of various tests and also to evaluate the accuracy of in vitro cytotoxicity assays.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
One significant disadvantage is the lack of uniform cytotoxicity test methods. Aside from that, there is no standardized protocol for performing cytotoxicity assays.
During the forecast period, North America is expected to hold one of the largest shares of the global cytotoxicity assays market. The region's drivers include an increase in haematology and cell proliferation studies, oncology studies, and a variety of other cell-based studies.
Principal Consultant
According to Future Market Insights, Asia-Pacific countries, particularly India and China, are expected to grow at a significant rate over the assessment period. Factors such as a significant increase in the import of these assay kits from leading global manufacturers, as well as the presence of local manufacturers with R&D facilities in the region will drive the growth of the cytotoxicity assays market in this region. Japan, with its high R&D investments in medical devices and well-established healthcare infrastructure, will pave the way for the country's cytotoxicity assay market to grow.
Some of the key participants present in the global Cytotoxicity Assays market include F. Hoffman-La Roche AG Thermo Fisher Scientific, Inc, Danaher Corporation, Sakura Finetechnical Co., Ltd and Laboratory Corporation of America Holdings Merck KGaA among others.
Attributed to the presence of such high number of participants, the market is highly competitive.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 9.1% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Billion, Volume in Kilotons and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered | Product Type, Application, End User, Region |
| Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; Middle East & Africa |
| Key Countries Profiled | USA, Canada, Brazil, Mexico, Germany, UK, France, Spain, Italy, Nordics, BENELUX, Russia, Australia & New Zealand, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, GCC, South Africa |
| Key Companies Profiled | F. Hoffman-La Roche AG; Thermo Fisher Scientific Inc.; Danaher Corporation; Sakura Finetechnical Co., Ltd; Laboratory Corporation of America Holdings; Merck KGaA |
| Customization | Available Upon Request |
Product Type:
Application:
End User Type:
Region:
FMI projects the global Cytotoxicity Assays market to expand at a 9.1% value CAGR by 2032
Asia Pacific is expected to be the most opportunistic Cytotoxicity Assays market.
F. Hoffman-La Roche AG Thermo Fisher Scientific, Inc, Danaher Corporation and Sakura Finetechnical Co., Ltd, are some prominent Cytotoxicity Assays manufacturers
Explore Healthcare Insights
View Reports
Cytotoxicity Assays Market
